GlobalMed Logistix (GMLx), LLC, a healthcare third party logistics provider has expanded its operational footprint by an additional 200% with the opening of its campus in Norcross, Georgia.
200% Expansion Completed for Healthcare 3PL Provider

The 65,000 square foot expansion facility completes the 125,000 square foot GMLx Atlanta Campus. The expansion is part of GMLx’s growth strategy. The new facility will enable GMLx to add additional medical device manufacturer customers while also enhancing GMLx service capabilities for existing partners. Looking forward, the company will continue to respond to customer needs by adding specialty services.
GMLx President and Chief Operating Officer Scott Vane commented, “At GMLx, we believe in our mantra of ‘together we grow’ and this expansion is a testament to the power of that collaboration.”
Vane continued, “Over the past year, we’ve welcomed a remarkable number of team members and supported a record number of customers and transactions. The collective strides we’ve made have not only strengthened our organization but have positively impacted the customers and patients we serve. As we look to the future, we’re excited about this opportunity to continue that growth.”
The new facility includes quality control services, tissue distribution services, and cold chain logistics services. The expansion is a medical device grade facility which offers, per the press release, “a dedicated environmental control room to meet the demands of devices with stringent temperature and humidity requirements.” There is also a “segregated, 5,700 square foot area dedicated to quality control services which include AQL [Acceptable Quality Limit] inspections, functional testing, and supplier coordination for sterilization.”
GMLx Vice President of Sales Hunter Fleetwood stated, “We are proud of our role in the medical device supply chain and that we get the opportunity to help our customers support patients every single day.”
Fleetwood continued, “This expansion allows GMLx to continue our focus of providing the best services and service levels in the industry so that our customers can continue to deliver life-changing products to facilities all over the world. Our vision is to positively impact the lives of over one million patients every year and this additional facility is a key factor in helping us achieve that goal.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.